All Biotech News

List of articles in category All Biotech News
Title	Published Date
CellGenix Appoints Leading Experts to Scientific Advisory Board	05/15/2017
BioNTech Announces Positive Results of an International Reproducibility Study with MammaTyper®	05/15/2017
Isarna Presents Positive Clinical Data for ISTH0036 in Advanced Glaucoma and Preclinical Data Supportive of AMD/DME Potential at ARVO 2017 Annual Conference	05/15/2017
NeuroDigm Uses Tissue Repair in an Innovative Nerve Pain Model	05/12/2017
BioPharmaSpec Announces Expansion of In-house Analytical Capabilities	05/09/2017
Sartorius Stedim Biotech Launches Chemistry Testing Services	05/04/2017
AlzProtect : The American Food and Drug Administration (FDA) Has Granted AZP2006 the Orphan Drug Designation for the Treatment of Progressive Supranuclear Palsy (PSP)	05/04/2017
Hookipa Biotech Presents Positive Data from Phase 1 First-In-Human Trial of Vaccine Against Cytomegalovirus	05/04/2017
Sartorius Stedim Biotech Introduces New BIOSTAT STR® Bioreactor Range	04/28/2017
RedHill Biopharma Announces Enrollment of Last Patient in the BEKINDA® Phase II Study for IBS-D	04/24/2017
Polyganics Announces Enrollment of the First Patient in its PROTECT NEURO Study	04/20/2017
Reinhard Kandera Appointed Chief Financial Officer of Hookipa Biotech	04/19/2017
RedHill Biopharma Receives Notice of Allowance for Two Additional U.S. Patents Covering BEKINDA®	04/18/2017
Agendia Appoints Patrick J. Balthrop Sr., Former CEO of Luminex, as Chairman	04/12/2017
LDC and SOTIO Enter License and Collaboration Agreement for First-in-class Cancer Metabolism Program	04/11/2017
LifeCodexx and Charité to Form Research Alliance Following Successful Clinical Proof-Of Principle for Molecular Genetic-Based Preeclampsia Assay	04/11/2017
Asceneuron Receives Regulatory Approval for Phase I Healthy Volunteer Study of Oral Tau Inhibitor	04/06/2017
RedHill Biopharma Announces Exclusive U.S. License from Entera Health for Commercial GI Product EnteraGam®	04/05/2017
RedHill Biopharma Receives FDA Orphan Drug Designation for YELIVA® for the Treatment of Cholangiocarcinoma	04/04/2017
NBE-Therapeutics Expands Board of Directors by the Appointment of Hans-Peter Gerber	04/04/2017
Australia’s Bionic Vision Technologies Raises USD18 Million (AUD23.5 M) to Develop ‘Bionic Eye’ for Global Markets	04/03/2017
Imanova Receives £1M Award from the MRC To Develop Early Markers of Dementia – the MIND-MAPS Study	04/03/2017
Calypso Biotech Licenses CALY-001 Best-In-Class Anti-MMP-9 Antibody to EA Pharma	03/31/2017
Vetter’s Dr. Claudia Roth is Appointed to the Fraunhofer Advisory Board	03/28/2017
Selvita and Menarini Group Announce Global License Agreement for Clinical Stage Oncology Drug PIM/FLT3 Inhibitor SEL24	03/28/2017
Chemotherapy as a Tablet Instead of an Intravenous Infusion: A Benefit for the Patient	03/27/2017
RedHill Biopharma Announces First Patient Dosed in the Open-Label Extension Study to the Phase III Study with RHB-104 for Crohn’s Disease	03/21/2017
European Group on Tumour Markers (EGTM) Updated Guidelines Recommend Agendia’s MammaPrint® Test with Highest Level 1A Clinical Evidence	03/21/2017
Selvita Announces First Patient Dosed in Phase I/II Clinical Trial of SEL24 in Acute Myeloid Leukemia	03/17/2017
Genomic Health Unveils a Wealth of Data for the Oncotype DX® Breast Cancer Test, Reinforcing Its Value in Improving Patient Outcomes and Leading to More Cost-Effective Management	03/17/2017

Page 42 of 88